GlaxoSmithKline (GSK) and iTeos Therapeutics are to co-develop and co-commercialise EOS-448, an anti-TIGIT monoclonal antibody currently in phase I development as a potential treatment for patients with cancer. TIGIT, part...

View the Online Magazine

- Advertisement -

Launches

Beckman Coulter launches Access AMH Advanced – an innovative test for clinicians to better personalize IVF treatments

Beckman Coulter, a global leader in diagnostics and infertility testing, announced today the launch of the first and only test that uses a validated...

Beckman Coulter launch workflow automation for mid-volume labs

Beckman Coulter, a clinical diagnostics leader, has announced the European launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized...

Newly launched British biotech pioneers ground-breaking potential treatments for COVID-19

A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

In brief: Moderna & Magenta partner to Distribute COVID vaccine in UAE

Moderna and Magenta Investments, part of an investment and industrial conglomerate in the United Arab Emirates (UAE), have forged a new agreement to distribute...

Pfizer and BioNTech to supply EU with 1.8bn additional Comirnaty doses

Pfizer and BioNTech have announced a new agreement with the European Commission (EC) to supply 900 million doses of Comirnaty, the companies’ COVID-19 vaccine,...

Pfizer & BioNTech to supply EU with 100m additional comirnaty doses

Pfizer and BioNTech will supply an additional 100 million doses of comirnaty, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states...

UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is ‘safe and effective’

The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) reaffirmed the  benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh...

Approvals

Accelerated approval for Aduhelm for Alzheimer’s treatment

Biogen and Eisai have been granted accelerated approval by the US FDA for Aduhelm (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to...

Comirnaty receives first authorisation in EU for COVID vaccine in adolescents

Conditional Marketing Authorisation (CMA) for Pfizer and BioNTech’s Comirnaty has been expanded to included individuals 12 to 15 years of age in the EU. This...

Manufacturiung

Finance

Research & Development
Latest

GSK and iTeos collaborate on anti-TIGIT monoclonal antibody

GlaxoSmithKline (GSK) and iTeos Therapeutics are to co-develop and co-commercialise EOS-448, an anti-TIGIT monoclonal antibody currently in phase I development as a potential treatment...

Caraway & AbbVie to develop novel small molecule therapeutics for Parkinson’s disease

Caraway Therapeutics has entered into an exclusive collaboration and option agreement with AbbVie to develop and commercialise Caraway’s small molecule therapeutics targeting TMEM175, a...

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from...

OliX subsidiary to advance development of mRNA vaccines & therapeutics

mCureX, a subsidiary of RNAi therapeutic developer, OliX Pharmaceuticals, has signed memorandums of understanding with Samyang Holdings to advance development of a messenger ribonucleic...

Theramex to commercialise denosumab from Enzene Biosciences

Theramex, a leading global speciality pharmaceutical company dedicated to women and their health, has entered into an agreement to register and commercialise denosumab from...

Appointments

- Advertisement -